Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA’s 84th Scientific Sessions

Innovent Biologics, Inc. announces that it will present multiple clinical study results of mazdutide at the American Diabetes Association’s® 84th Scientific Sessions in Orlando from June 21 -24.

Scroll to Top